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Abstract: 
Vesicoureteral reflux (VUR), the retrograde flow of urine from the bladder toward 
the kidney, is congenital and often familial. VUR is common in childhood, but its 
precise prevalence is uncertain. It is about 10–20% in children with antenatal 
hydronephrosis, 30% in siblings of patient with VUR and 30–40% in children with 
a proved urinary tract infection (UTI). Ultrasonography is a useful initial revision 
but diagnosis of VUR requires a voiding cystourethrography (VCUG) or 
radionuclide cystogram (DRNC) and echo-enhanced voiding urosonography 
(VUS). Although for most, VUR will resolve spontaneously, the management of 
children with VUR remains controversial. We summarized the literature and paid 
attention to the studies whose quality is not adequate in the field of VUR 
management of children.  
Key Words: Vesicoureteral Reflux, Urinary Tract Infection, Antenatal 
Hydronephrosis 
 
 
 
 
 
Introduction: 
Vesicoureteral reflux (VUR) is described as the retrograde flow of urine from 
the bladder into the ureter and renal pelvis secondary to a dysfunctional 
vesicoureteral junction 
[1, 2, 3]
. Reflux into parenchyma of renal is defined as the 
intrarenal reflux 
[4,5]
. This junction who is oblique, between the bladder mucosa and 
detrusor muscle usually acts like a one-way valve that prevents VUR. VUR is 
caused by lateral or proximal dystopia of the orifice of ureter in bladder 
[6]
. VUR is 
the most common congenital anomaly of the urinary tract. VUR predisposes to 
urinary tract infection (UTI) through facilitating the transport of pathogen bacteria 
from the bladder to the upper urinary tract. The inflammatory reaction caused by 
UTI can result in reflux nephropathy (RN).  RN can lead to proteinuria, renin-
mediated hypertension, renal insufficiency, impaired somatic growth and morbidity 
during pregnancy, too 
[7]
. RN is a result of abnormal renal development leading to 
focal or extended renal dysplasia 
[7, 8]
. In children with VUR and UTI, the incidence 
of renal scarring is higher at 30-56% 
[7]
. The prevalence of primary VUR (PVUR) 
is 1%- 6% with dominant inheritance and variable penetrance 
[8-11]
, while this is 
likely an underestimate because of phenotypic heterogeneity and the lack of non-
invasive and non-dangerous diagnostic tools. VUR is detected most commonly 
during voiding, when intravesical pressure rises, but may occur any time in the 
voiding cycle, particularly when bladder function is abnormal. VUR is common in 
childhood, whereas precise prevalence is uncertain since large-scale population 
screening using VCUG has not been done due to the dangers and cannot be 
justified 
[12-15]
. Evaluation of children of parents with VUR showed that 66 % had 
VUR, indicating a significant parent-to-child transmission. A follow-up study 
showed that 75% of children identified with VUR by sibling screening were 
asymptomatic 
[7]
. 
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VUR does not usually cause renal injury in the 
absence of the risk factor. Severity is graded using the 
height of retrograde flow, and dilation and tortuosity of 
the ureters. This is important because VUR usually will 
spontaneously resolve with rise of age 
[12, 13]
. 
Spontaneous resolution of VUR in children due to the 
natural elongation of the vesicoureteral junction is 
possible, especially in patients without risk factor 
[14]
. 
Although the spontaneous resolution of VUR has been 
observed in many patients, the management of VUR 
remains multifactorial and individualized 
[15-18]
. There 
are controversial issues about the treatment of renal 
abnormalities detected by VCUG 
[17]
.  
The aim of this study was to describe VUR in 
children, to pay more attention to the studies whose 
quality is not adequate in the field of management, 
prognosis and complications of VUR in Iranian and 
global children and to focus on the need of research in 
this area. 
 
 
Clinical Manifestations:  
VUR as a genetic condition can facilitate the 
detection in other family members before clinical 
presentation 
[1, 19]
. VUR can be an isolated finding and 
called primary reflux, or associated with others 
malformation. Primary VUR is often diagnosed via one 
of three ways: a) the follow-up period after UTI, b) 
through surveying the infants with previous history of 
antenatal hydronephrosis, c) by screening a sibling of a 
patient with VUR 
[7]
. VUR usually is discovered during 
evaluation of UTI 
[2,3, 15]
. Bladder and bowel 
dysfunction may be present in the management of more 
than half of children with VUR and recurrent UTI, 
which finally may lead to renal scarring and kidney 
failure 
[15,16, 17, 20]
. 
 
 
Diagnosis: 
The role of imaging is to evaluate for underlying 
urologic abnormalities for VUR and guide treatment. 
Detection of a condition before disease occurrence is 
justified when early intervention improves the 
outcomes for the patient. Ultrasonography is a useful 
initial revision to evaluate for renal and urinary system 
[21, 22]
. Ultrasonography is the initial modality for the 
evaluation of postnatal hydronephrosis and UTI in 
children. Ultrasonography has been used to identify 
other urological abnormalities and has the benefit of 
being radiation free. Ultrasound is normal in lower 
grades of VUR, and overall, it is poor to identify the 
VUR. Ultrasound has also been utilized in the follow-
up evaluation of children after surgical correction of 
VUR and screening a sibling of a patient with VUR 
[6,7]
. With the rapid improvement of ultrasound 
technology, the incidence of detection of renal 
anomalies is increased. Hydronephrosis is the most 
common congenital disorder, diagnosed by prenatal 
ultrasonography 
[23]
. Some authors advise to perform 
all the diagnostic investigations for infants with 
prenatal hydronephrosis, but nowadays VCUG is 
recommended only in few selective cases 
[24-26]
. 
According to previous studies, sonography cannot be a 
sensitive method to diagnose the UTI and VUR, while 
ultrasound study is helpful to detect the anatomical 
evaluation 
[27-30]
. It is necessary to early diagnose the 
hydronephrosis and to reduce its complications. 
Diagnosis of VUR requires a VCUG or DRNC and 
echo-enhanced voiding urosonography (VUS) 
[31, 32]
. 
However, the contrast VCUG provides more sensitive 
anatomic information but serves the radiation exposure 
[15, 16]
. The bladder and if with VUR is preserd upper 
urinary tracts are imaged during bladder filling, 
voiding and post voiding. The gold standard for 
evaluation of children for VUR is VCUG, especially in 
male 
[7- 9]
. The VCUG required catheterization and if 
with VUR presented an invasive diagnostic procedure 
that leads to significant stress among the children and 
their parents. The VCUG should be obtained as soon as 
the child has completed the course of antibiotic therapy 
for UTI. Evaluation with VCUG has been suggested 
after the first febrile infection in children younger than 
age 5. Radiation exposure is significantly less by using 
a DRNC than a contrast VCUG. So the former is 
preferred for follow-up evaluation 
[7]
. 
VUS is an increasingly popular alternative for 
diagnosing and monitoring VUR 
[2, 22]
.  
In one study, the correlation between the midline-
to-orifice distances (MOD) measured by 
ultrasonography and VUS was compared to detect the 
VUR in children 
[31]
. The VUR grading system is based 
on the appearance, dilation and tortuosity observed 
during the study 
[5]
.  
 
 
Prognosis: 
The voiding reflux is associated with a majority rate 
of spontaneous resolution and the filling reflux is more 
likely to need surgical intervention 
[33, 34]
. The VUR is 
not the disease itself; it is maybe only one symptom of 
a syndrome so early diagnostic examination is 
mandatory for every child with suspicious event 
[35]
. 
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VUR grading in children is of high prognostic 
relevance 
[15, 16]
. Although for most children, VUR will 
spontaneously resolve in time, the management of 
children with VUR remains controversial, yet 
[15, 16]
.  
The likelihood of spontaneous resolution is affected 
by recurrent UTI, grade of VUR, age at diagnosis, 
male, low bladder volume in VUR and bladder 
dysfunction, and the presence of other urinary tract 
malformation 
[13, 33]
. VUR does not usually cause renal 
injury in the absence of infection, but in situations with 
high-pressure VUR, sterile VUR can cause significant 
renal damage 
[12- 16]
. History of VUR was not 
associated with accelerated ESKD 
[36]
. 
In some studies, a significant association has been 
reported between VUR and nephrolithiasis by an 
increased prevalence of hypercalciuria in children and 
their family members 
[37- 39]
.  
 
 
Treatment: 
Major efforts have been made in the past to 
improve the detection and follow-up of VUR in 
children. Though the management of children with 
VUR still remains cryptic, the best way of therapy in 
children with VUR should be the prevention of 
complications caused by relapsing pyelonephritis and 
reflux nephropathy 
[12, 13, 34]
. Available management 
options include close monitoring and early treatment of 
pyelonephritis, long-term antibiotic prophylaxis, 
follow-up renal imaging to assess the resolution of 
VUR and reflux nephropathy, appropriate management 
of voiding dysfunction and constipation and surgical 
correction on demand or need 
[20, 30]
. The three main 
treatment modalities that have been practiced are long-
term antimicrobial prophylaxis, surgical correction and 
no routine prophylaxis or surgical intervention. Many 
studies have raised serious doubts about the relevance 
of long-term antimicrobial prophylaxis in the 
prevention of recurrent UTI and secondary renal injury 
in patients with VUR. 
In children older than 2 months with first episode of 
uncomplicated UTI, there is no need for prophylactic 
antibiotic and routine imaging as VUR, but the 
ultrasound is usually appropriate. In children with 
recurrent or complicated UTI, imaging of VUR is 
usually appropriate 
[20, 40]
. Continuous antibiotic 
prophylaxis (CAP) is recommended as the initial 
treatment option in patients classified in less risk group 
without low urinary tract disorder and anomaly 
[41]
. 
CAP is recommended in children at greatest risk for 
VUR-related renal injury, for evaluation of bladder and 
bowel dysfunction and in children with VUR, who 
have febrile UTI 
[8]
. Some researchers believe that CAP 
should be recommended for patients with VUR 
diagnosed after febrile UTI and with high grade VUR 
diagnosed through screening 
[7]
. 
The antimicrobial agents most appropriate for 
prophylaxis include trimethoprim-sulfamethoxazole 
(TMP-SMZ), trimethoprim alone, nitrofurantoin, or 
cephalexin 
[7]
. However, the decision to use antibiotic 
prophylaxy in children with VUR remains a clinical 
dilemma and uncertain question. Disadvantages of 
prophylactic antibiotic therapy are the side effects and 
development of resistant organisms in the host 
[7, 8, 42]
. 
 The authors concluded that there was no 
superiority of surgical treatment over medical 
management of VUR in children 
[7]
. Surgical correction 
is recommended for VUR: 
Patients with grade V after one year old, patients 
with progression of renal scarring while on antibiotic 
prophylaxis, patients with progression of VUR grade, 
patients with frequent relapsing pyelonephritis, 
particularly those who have breakthrough UTI or renal 
scarring and for the non-compliant patient 
[7, 43]
.  
Endoscopic treatment (ET) which is the injection of 
bulking agents in the subureteral space has been 
suggested as a treatment modality for VUR. The 
indications for endoscopic injection are unclear at 
present. ET is the gold standard for symptomatic low-
grade VUR in children 
[44]
. ET is effective at 
eliminating VUR in children, even in patients with 
high-grade reflux or in patients with VUR and 
additional malformations and alternative to continuous 
prophylactic antibiotic administration. ET may reduce 
the incidence of UTIs and prevent long-term renal 
damage. The cure rate of VUR with this procedure is 
approximately 60–70% with first treatment [43, 45]. 
DRNC is very useful to determine the resolution of 
reflux during follow-up or after surgical correction.  
Though most practitioners do it yearly, the timing for 
follow-up is not well defined,. Some researchers 
recommended the VCUG from yearly to every 2 years 
in children with mild VUR (grades I and II) and every 
3 years in children with moderate to severe VUR 
(grades III or higher)
 [7, 8]
. 
 
 
Conclusion: 
VUR is a common pediatric problem and 
predisposing factor for UTI and 25-40% of children 
with UTI have VUR 
[22, 46, 47]
. The incidence of VUR in 
children is still unknown many studies have assessed 
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whether the approach to diagnosis and medical or 
surgical interventions can decrease the recurrence of 
UTI in children with VUR. We reviewed the current 
literature on it, but the clinical trialis needed to 
determine the increasing prevalence, efficacy and 
effectiveness of approach, diagnosis and alternative 
treatments for children with VUR.  
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